It is expensive - a potent intravenous infusion of antibodies to neutralise the virus, rather than dampen the body's inflammatory response to it.
Results from the Recovery trial suggest it could help one in three of those in hospital with severe Covid. BBC News
See also:
- Covid jab 'compulsory' for England care home staff BBC News
- What are the Delta variant symptoms? BBC News
- England needs to speed up vaccine rollout by 12% to meet targets for July 19, analysis shows The Daily Mail
- Covid survivors say they experience 'bizarre' tastes and smells months after clearing the infection The Daily Mail
- One in three patients admitted to hospital during first Covid wave received DNR orders, study shows The Daily Mail
- Coronavirus: SAGE warned Covid admissions could spike past 7,000 a day with Indian variant The Daily Mail
- Britain has Europe's WORST Covid outbreak as Indian variant sees nation overtake Spain The Daily Mail
- Mapped: The hotspots for the Delta variant of Covid-19 in the UK The Daily Telegraph
- Compulsory jabs for NHS and care staff to be announced The Daily Telegraph
- All adults in England able to book Covid jabs ‘by end of week’ The Guardian
- Why is Israel lifting Covid restrictions as England extends them? The Guardian
No comments:
Post a Comment